European Pre-Market Summary - 16th November 2026: European bourses set for a flat open
ORIGINAL · NewsquawkEuropean Pre-Market Summary - 16th November 2026: European bourses set for a flat openRead originalHide original
Stories: AstraZeneca (AZN LN): Co. reportedly cut c. 600 jobs across its US respiratory and immunology commercial teams as part of efforts to reallocate resources towards its drug development pipeline, according to Bloomberg sources. Barclays (BARC LN): Co. is reportedly preparing to cut c. 200 investment banking jobs, primarily in New York and London, as early as Tuesday, according to Bloomberg sources. Stellantis (STLAM IM/STLAP FP): Canadian Industry Minister Joly says the Co. owes the government hundreds of millions of dollars after failing to restart production at a plant near Toronto. Healthcare Updates: Novartis (NOVN SW): Co. announces that it received a positive CHMP opinion of Cosentyx for adolescents aged 12 years and older. Roche (ROP SW): Co. announces that the US FDA has approved Gazyva/Gazyvaro for the treatment of adult patients with primary membranous nephropathy at risk of disease progression. Novo Nordisk (NOVOB DC): Co. reported positive Phase 3 Redefine 9 results for lower-dose CagriSema in overweight or obese adults. At week 68, doses of 1.7mg/1.7mg and 1.0mg/1.0mg achieved estimated average weight loss of 20.7% and 21.0%, respectively, versus 2.0% with placebo. Broker Moves: Generali (G IM) downgraded to Reduce from Add at AlphaValue Geberit (GEBN SW) downgraded to Hold from Buy at Jefferies Holcim (HOLN SW) upgraded to Buy from Hold at Jefferies
The European pre-market summary flagged a flat open and company-specific developments, while prior reports put Barclays’ planned cuts in a wider workforce context and detailed Ottawa’s action against Stellantis.
News detail
Stories: AstraZeneca (AZN LN): Co. reportedly cut c. 600 jobs across its US respiratory and immunology commercial teams as part of efforts to reallocate resources towards its drug development pipeline, according to Bloomberg sources. Barclays (BARC LN): Co. is reportedly preparing to cut c. 200 investment banking jobs, primarily in New York and London, as early as Tuesday, according to Bloomberg sources. Stellantis (STLAM IM/STLAP FP): Canadian Industry Minister Joly says the Co. owes the government hundreds of millions of dollars after failing to restart production at a plant near Toronto. Healthcare Updates: Novartis (NOVN SW): Co. announces that it received a positive CHMP opinion of Cosentyx for adolescents aged 12 years and older. Roche (ROP SW): Co. announces that the US FDA has approved Gazyva/Gazyvaro for the treatment of adult patients with primary membranous nephropathy at risk of disease progression. Novo Nordisk (NOVOB DC): Co. reported positive Phase 3 Redefine 9 results for lower-dose CagriSema in overweight or obese adults. At week 68, doses of 1.7mg/1.7mg and 1.0mg/1.0mg achieved estimated average weight loss of 20.7% and 21.0%, respectively, versus 2.0% with placebo. Broker Moves: Generali (G IM) downgraded to Reduce from Add at AlphaValue Geberit (GEBN SW) downgraded to Hold from Buy at Jefferies Holcim (HOLN SW) upgraded to Buy from Hold at Jefferies
Related stocks
2 stocksWhat do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
